HTG Molecular Diagnostics, Inc. Current Portion of Long-Term Debt
HTG Molecular Diagnostics, Inc. had Current Portion of Long-Term Debt of $3.08 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:LongTermDebtCurrent · last filed 2023-05-11
- 2023-03-31: Long-term Debt, Current Maturities $3.08M.
- 2022-12-31: Long-term Debt, Current Maturities $3.81M.
- 2022-09-30: Long-term Debt, Current Maturities $3.69M.
- 2022-06-30: Long-term Debt, Current Maturities $6.61M.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2023-03-31 | $3.08M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.81M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $3.69M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.61M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $5.00M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $5.17M 10-K · filed 2023-03-30 |
| 2021-09-30 | $4.17M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $3.16M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.50M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $3.02M 10-K · filed 2022-03-29 |
| 2020-09-30 | $2.27M 10-Q · filed 2020-11-10 |
| 2019-12-31 | $2.99M 10-K · filed 2021-03-25 |